Geneva, Switzerland and Boston, MA – February 7, 2018 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics…
Tag: 2018
Dr. Ernest Loumaye, CEO of ObsEva SA returns to work following a personal leave for medical reasons
Geneva, Switzerland and Boston, MA – February 1, 2018– ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics…
ObsEva Extraordinary General Meeting 2018
Friday, January 26, 2018 3:00 p.m. CET Supporting Materials:
Extraordinary General Meeting of Shareholders of ObsEva SA
ObsEva SA presentation at JPM Healthcare Conference (webcast Link)
ObsEva SA to Participate in JP Morgan Healthcare Conference January 8 – 11, 2018
Geneva, Switzerland and Boston, MA – January 5, 2018 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of…